Free tool
Drugs in development
Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations
Drugs in development
3,685
Not FDA-approved
In Phase 3
1,424
Highest phase reached
Matching your filters
236
236 drugs in development
Names, sponsors and conditions come from the trial records. Click a drug for its trials.
- ND0612ND0612HPhase 21 trial
NeuroDerm Ltd. · Parkinson's Disease
- NEU-411Phase 21 trial
Neuron23 Inc. · Parkinson Disease, Parkinson, Idiopathic Parkinson Disease
- NPT 2042Phase 21 trial
NeuroPro Therapeutics, Inc. · Epilepsy, Generalized, Epilepsy, Absence
- NS-050NCNP-03Phase 21 trial
NS Pharma, Inc. · Duchenne Muscular Dystrophy
- NSC001Phase 21 trial
NSC-Therapeutics · Alzheimer Disease
- NTRX-07MDA7Phase 21 trial
NeuroTherapia, Inc. · Alzheimer Disease, Mild Cognitive Impairment
- NX210cPhase 21 trial
Axoltis Pharma · Amyotrophic Lateral Sclerosis
- NYX-458Phase 21 trial
Aptinyx · Mild Cognitive Impairment, Mild Dementia, Parkinson Disease
- PIPE-307Phase 21 trial
Johnson & Johnson (Janssen) · Relapsing Remitting Multiple Sclerosis
- PLL001Phase 21 trial
PLL TX AUSTRALIA PTY LTD · Amyotrophic Lateral Sclerosis, ALS
- PRI-002ContraloidPhase 21 trial
PRInnovation GmbH · Mild Cognitive Impairment Due to Alzheimer's Disease, Alzheimer's Disease, Early Onset
- PRO-1562Phase 21 trial
Progentos Therapeutics · Multiple Sclerosis
- PRT-064040Phase 21 trial
Sichuan Purity Pharmaceutical Technology Co., Ltd. · Migraine
- RenadirsenDS-5141bPhase 21 trial
Daiichi Sankyo · Duchenne Muscular Dystrophy
- RinvaterceptKER-065Phase 21 trial
Keros Therapeutics, Inc. · Duchenne Muscular Dystrophy
- RNDP-001Phase 21 trial
Kenai Therapeutics · Idiopathic Parkinson´s Disease, Parkinson's Disease
- RO7268489Phase 21 trial
Roche (Genentech) · Progressive Multiple Sclerosis
- RO7269162Phase 21 trial
Roche (Genentech) · Alzheimer's Disease
- sabirnetugPhase 21 trial
Acumen Pharmaceuticals · Alzheimer Disease
- SAR448851Phase 21 trial
Sanofi · Dementia, Alzheimer's Type, Alzheimer's Disease
- SIR2501Phase 21 trial
Sironax USA, Inc. · Chemotherapy-induced Peripheral Neuropathy
- SNUG01Phase 21 trial
SineuGene Therapeutics Co., Ltd. · Amyotrophic Lateral Sclerosis (ALS)
- SUL-238t.i.d.Phase 21 trial
GEN İlaç ve Sağlık Ürünleri A.Ş. · Parkinson's Disease (PD)
- SUN-627NEU-627, N-004850Phase 21 trial
Sundance Biosciences, Inc. · Primary Progressive Multiple Sclerosis, Primary Progressive MS, Primary Progressive Multiple Sclerosis (PPMS)
- TAK-411Hypersialylated Immune Globulin GPhase 21 trial
Takeda · Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
- TB006Phase 21 trial
TrueBinding, Inc. · Parkinson's Disease (PD)
- TominersenRO7234292, RG6042Phase 21 trial
Roche (Genentech) · Huntington Disease
- TRCN-1023Phase 21 trial
Trace Neuroscience, Inc. · Amyotrophic Lateral Sclerosis
- TRX319Phase 21 trial
Tr1X, Inc. · Primary Progressive Multiple Sclerosis, Secondary Progressive Multiple Sclerosis (SPMS), Multiple Sclerosis
- UCB0022Phase 21 trial
UCB · Parkinson Disease
- VMD-3866Phase 21 trial
VM Therapeutics LLC · Chemotherapy-induced Peripheral Neuropathy, Chemotherapy-induced Neuropathic Pain, CIPN - Chemotherapy-Induced Peripheral Neuropathy
- VO659Phase 21 trial
Vico Therapeutics B. V. · Spinocerebellar Ataxia Type 1, Spinocerebellar Ataxia Type 3, Huntington Disease
- VT7208Phase 21 trial
Vidya Therapeutics Inc · Multiple Sclerosis
- VY7523Phase 21 trial
Voyager Therapeutics · Alzheimer's Disease (AD)
- XJN010Phase 21 trial
Guangzhou Novaken Pharm Co., Ltd. · Parkinson Disease
- XPro1595INB03, XProPhase 21 trial
Inmune Bio, Inc. · Alzheimer Disease, Dementia, Brain Diseases
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.